Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.75 INR | +0.90% |
|
-6.50% | -5.75% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 150.1 | 156.9 | 162.1 | 136.5 | 126 | 83.17 |
Enterprise Value (EV) 1 | 184.3 | 199.2 | 215.1 | 198.5 | 193.4 | 161.6 |
P/E ratio | 47.9 x | -23.4 x | -12.8 x | -23.9 x | -21 x | -12.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.12 x | 1.06 x | 1.04 x | 0.85 x | 0.55 x | 0.29 x |
EV / Revenue | 1.37 x | 1.35 x | 1.38 x | 1.24 x | 0.84 x | 0.57 x |
EV / EBITDA | 14.8 x | 35.3 x | 46.6 x | 24.2 x | 33.2 x | 30 x |
EV / FCF | 86.4 x | -28.7 x | -24 x | -28.5 x | -43.9 x | -15.6 x |
FCF Yield | 1.16% | -3.49% | -4.17% | -3.5% | -2.28% | -6.39% |
Price to Book | 2.12 x | 2.45 x | 3.15 x | 2.98 x | 3.17 x | -11.8 x |
Nbr of stocks (in thousands) | 4,265 | 4,265 | 4,265 | 4,265 | 4,265 | 4,265 |
Reference price 2 | 35.20 | 36.80 | 38.00 | 32.00 | 29.55 | 19.50 |
Announcement Date | 03/09/18 | 03/09/19 | 05/09/20 | 05/09/21 | 07/09/22 | 07/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 134.6 | 147.9 | 155.3 | 159.7 | 230.2 | 282.8 |
EBITDA 1 | 12.49 | 5.641 | 4.619 | 8.217 | 5.834 | 5.391 |
EBIT 1 | 5.089 | -1.929 | -2.977 | 0.8089 | -1.924 | -1.162 |
Operating Margin | 3.78% | -1.3% | -1.92% | 0.51% | -0.84% | -0.41% |
Earnings before Tax (EBT) 1 | -4.181 | -6.011 | -7.25 | -6.168 | -6.684 | -6.109 |
Net income 1 | 3.137 | -6.697 | -12.65 | -5.696 | -6.007 | -6.733 |
Net margin | 2.33% | -4.53% | -8.15% | -3.57% | -2.61% | -2.38% |
EPS 2 | 0.7355 | -1.570 | -2.970 | -1.340 | -1.409 | -1.580 |
Free Cash Flow 1 | 2.132 | -6.95 | -8.966 | -6.955 | -4.404 | -10.33 |
FCF margin | 1.58% | -4.7% | -5.77% | -4.35% | -1.91% | -3.65% |
FCF Conversion (EBITDA) | 17.07% | - | - | - | - | - |
FCF Conversion (Net income) | 67.97% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 03/09/18 | 03/09/19 | 05/09/20 | 05/09/21 | 07/09/22 | 07/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 34.2 | 42.2 | 53 | 62 | 67.4 | 78.5 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.734 x | 7.487 x | 11.48 x | 7.55 x | 11.55 x | 14.55 x |
Free Cash Flow 1 | 2.13 | -6.95 | -8.97 | -6.96 | -4.4 | -10.3 |
ROE (net income / shareholders' equity) | 4.53% | -9.92% | -21.9% | -11.7% | -14.1% | -41.2% |
ROA (Net income/ Total Assets) | 2.27% | -0.84% | -1.19% | 0.3% | -0.67% | -0.37% |
Assets 1 | 138.1 | 798.8 | 1,061 | -1,881 | 896.6 | 1,806 |
Book Value Per Share 2 | 16.60 | 15.00 | 12.10 | 10.70 | 9.310 | -1.650 |
Cash Flow per Share 2 | 1.330 | 2.570 | 1.900 | 2.150 | 1.410 | 2.040 |
Capex 1 | 4.84 | 4.92 | 7.02 | 3.78 | 9.34 | 3.94 |
Capex / Sales | 3.6% | 3.33% | 4.52% | 2.37% | 4.06% | 1.39% |
Announcement Date | 03/09/18 | 03/09/19 | 05/09/20 | 05/09/21 | 07/09/22 | 07/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-5.75% | 1.32M | |
-34.77% | 13.2B | |
+4.48% | 11.76B | |
-3.60% | 11.57B | |
+8.44% | 10.67B | |
+28.58% | 8.64B | |
-9.79% | 7.24B | |
+10.23% | 6.98B | |
+8.41% | 6.46B | |
0.00% | 4.99B |
- Stock Market
- Equities
- SML6 Stock
- Financials Soni Medicare Limited